Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Resolving the Mystery of the Elusive Peak: Negative Differential Resistance in Redox Proteins.

The journal of physical chemistry letters

Mentovich ED, Belgorodsky B, Richter S.
PMID: 26295313
J Phys Chem Lett. 2011 May 19;2(10):1125-8. doi: 10.1021/jz200304s. Epub 2011 Apr 25.

Vertical molecular transistors are used to explain the nonconformal electron transfer results obtained for redox proteins. The transport characteristics of a negative differential resistance peak as appears in the transport data of azurin and its nonredox derivative are explored....

Cite
Mentovich ED, Belgorodsky B, Richter S. Resolving the Mystery of the Elusive Peak: Negative Differential Resistance in Redox Proteins. J Phys Chem Lett. 2011;2(10):1125-8doi: 10.1021/jz200304s.
Mentovich, E. D., Belgorodsky, B., & Richter, S. (2011). Resolving the Mystery of the Elusive Peak: Negative Differential Resistance in Redox Proteins. The journal of physical chemistry letters, 2(10), 1125-8. https://doi.org/10.1021/jz200304s
Mentovich, Elad D, et al. "Resolving the Mystery of the Elusive Peak: Negative Differential Resistance in Redox Proteins." The journal of physical chemistry letters vol. 2,10 (2011): 1125-8. doi: https://doi.org/10.1021/jz200304s
Mentovich ED, Belgorodsky B, Richter S. Resolving the Mystery of the Elusive Peak: Negative Differential Resistance in Redox Proteins. J Phys Chem Lett. 2011 May 19;2(10):1125-8. doi: 10.1021/jz200304s. Epub 2011 Apr 25. PMID: 26295313.
Copy Download .nbib Format: NLM
Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting.

Bioresource technology

Ghosh S, Coons J, Yeager C, Halley P, Chemodanov A, Belgorodsky B, Gozin M, Chen GQ, Golberg A.
PMID: 34728090
Bioresour Technol. 2022 Jan;344:125964. doi: 10.1016/j.biortech.2021.125964. Epub 2021 Oct 31.

The present study tested the outdoor cultivation of Haloferax mediterranei for PHA production from green macroalgae Ulva sp. in pneumatically agitated bioreactors and applied ultrasonic separation for enhanced settling of archaeal cells. Scaled-up cultivation (40 L) yielded maximum biomass...

Cite
Ghosh S, Coons J, Yeager C, et al. Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting. Bioresour Technol. 2021;344:125964doi: 10.1016/j.biortech.2021.125964.
Ghosh, S., Coons, J., Yeager, C., Halley, P., Chemodanov, A., Belgorodsky, B., Gozin, M., Chen, G. Q., & Golberg, A. (2022). Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting. Bioresource technology, 344125964. https://doi.org/10.1016/j.biortech.2021.125964
Ghosh, Supratim, et al. "Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting." Bioresource technology vol. 344 (2022): 125964. doi: https://doi.org/10.1016/j.biortech.2021.125964
Ghosh S, Coons J, Yeager C, Halley P, Chemodanov A, Belgorodsky B, Gozin M, Chen GQ, Golberg A. Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting. Bioresour Technol. 2022 Jan;344:125964. doi: 10.1016/j.biortech.2021.125964. Epub 2021 Oct 31. PMID: 34728090.
Copy Download .nbib Format: NLM
Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.

Hormone research in paediatrics

Vaiani E, Felizzia G, Lubieniecki F, Braier J, Belgorosky A.
PMID: 34167121
Horm Res Paediatr. 2021;94(1):9-17. doi: 10.1159/000517040. Epub 2021 Jun 24.

Langerhans cell histiocytosis (LCH) is a disorder of the mononuclear phagocyte system that can affect almost any organ and system. The most common central nervous system (CNS) manifestation in LCH is the infiltration of the hypothalamic-pituitary region leading to...

Cite
Vaiani E, Felizzia G, Lubieniecki F, et al. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System. Horm Res Paediatr. 2021;94(1):9-17doi: 10.1159/000517040.
Vaiani, E., Felizzia, G., Lubieniecki, F., Braier, J., & Belgorosky, A. (2021). Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System. Hormone research in paediatrics, 94(1), 9-17. https://doi.org/10.1159/000517040
Vaiani, Elisa, et al. "Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System." Hormone research in paediatrics vol. 94,1 (2021): 9-17. doi: https://doi.org/10.1159/000517040
Vaiani E, Felizzia G, Lubieniecki F, Braier J, Belgorosky A. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System. Horm Res Paediatr. 2021;94(1):9-17. doi: 10.1159/000517040. Epub 2021 Jun 24. PMID: 34167121.
Copy Download .nbib Format: NLM
Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting.

Bioresource technology

Ghosh S, Coons J, Yeager C, Halley P, Chemodanov A, Belgorodsky B, Gozin M, Chen GQ, Golberg A.
PMID: 34728090
Bioresour Technol. 2022 Jan;344:125964. doi: 10.1016/j.biortech.2021.125964. Epub 2021 Oct 31.

The present study tested the outdoor cultivation of Haloferax mediterranei for PHA production from green macroalgae Ulva sp. in pneumatically agitated bioreactors and applied ultrasonic separation for enhanced settling of archaeal cells. Scaled-up cultivation (40 L) yielded maximum biomass...

Cite
Ghosh S, Coons J, Yeager C, et al. Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting. Bioresour Technol. 2021;344:125964doi: 10.1016/j.biortech.2021.125964.
Ghosh, S., Coons, J., Yeager, C., Halley, P., Chemodanov, A., Belgorodsky, B., Gozin, M., Chen, G. Q., & Golberg, A. (2022). Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting. Bioresource technology, 344125964. https://doi.org/10.1016/j.biortech.2021.125964
Ghosh, Supratim, et al. "Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting." Bioresource technology vol. 344 (2022): 125964. doi: https://doi.org/10.1016/j.biortech.2021.125964
Ghosh S, Coons J, Yeager C, Halley P, Chemodanov A, Belgorodsky B, Gozin M, Chen GQ, Golberg A. Halophyte biorefinery for polyhydroxyalkanoates production from Ulva sp. Hydrolysate with Haloferax mediterranei in pneumatically agitated bioreactors and ultrasound harvesting. Bioresour Technol. 2022 Jan;344:125964. doi: 10.1016/j.biortech.2021.125964. Epub 2021 Oct 31. PMID: 34728090.
Copy Download .nbib Format: NLM
Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center.

Journal of pediatric endocrinology & metabolism : JPEM

Mattone MC, Gil S, Costanzo M, Galluzzo Mutti ML, Casanovas A, Zaidman V, Lazzati JM, Ciaccio M, Belgorosky A, Guercio G.
PMID: 34674406
J Pediatr Endocrinol Metab. 2021 Oct 21; doi: 10.1515/jpem-2021-0392. Epub 2021 Oct 21.

Pediatric adrenocortical tumors are rare and heterogeneous endocrine malignancies.OBJECTIVES: To report clinical, biochemical, and histological features, staging, and therapeutic interventions in a cohort of 28 patients treated at a single tertiary center.METHODS: A retrospective review of medical records of...

Cite
Mattone MC, Gil S, Costanzo M, et al. Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. J Pediatr Endocrinol Metab. 2021;doi: 10.1515/jpem-2021-0392.
Mattone, M. C., Gil, S., Costanzo, M., Galluzzo Mutti, M. L., Casanovas, A., Zaidman, V., Lazzati, J. M., Ciaccio, M., Belgorosky, A., & Guercio, G. (2021). Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. Journal of pediatric endocrinology & metabolism : JPEM, . https://doi.org/10.1515/jpem-2021-0392
Mattone, María Celeste, et al. "Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center." Journal of pediatric endocrinology & metabolism : JPEM vol. (2021). doi: https://doi.org/10.1515/jpem-2021-0392
Mattone MC, Gil S, Costanzo M, Galluzzo Mutti ML, Casanovas A, Zaidman V, Lazzati JM, Ciaccio M, Belgorosky A, Guercio G. Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. J Pediatr Endocrinol Metab. 2021 Oct 21; doi: 10.1515/jpem-2021-0392. Epub 2021 Oct 21. PMID: 34674406.
Copy Download .nbib Format: NLM
Gene expression signatures predict response to therapy with growth hormone.

The pharmacogenomics journal

Stevens A, Murray P, De Leonibus C, Garner T, Koledova E, Ambler G, Kapelari K, Binder G, Maghnie M, Zucchini S, Bashnina E, Skorodok J, Yeste D, Belgorosky A, Siguero JL, Coutant R, Vangsøy-Hansen E, Hagenäs L, Dahlgren J, Deal C, Chatelain P, Clayton P.
PMID: 34045667
Pharmacogenomics J. 2021 Oct;21(5):594-607. doi: 10.1038/s41397-021-00237-5. Epub 2021 May 27.

Recombinant human growth hormone (r-hGH) is used as a therapeutic agent for disorders of growth including growth hormone deficiency (GHD) and Turner syndrome (TS). Treatment is costly and current methods to model response are inexact. GHD (n = 71)...

Cite
Stevens A, Murray P, De Leonibus C, et al. Gene expression signatures predict response to therapy with growth hormone. Pharmacogenomics J. 2021;21(5):594-607doi: 10.1038/s41397-021-00237-5.
Stevens, A., Murray, P., De Leonibus, C., Garner, T., Koledova, E., Ambler, G., Kapelari, K., Binder, G., Maghnie, M., Zucchini, S., Bashnina, E., Skorodok, J., Yeste, D., Belgorosky, A., Siguero, J. L., Coutant, R., Vangsøy-Hansen, E., Hagenäs, L., Dahlgren, J., Deal, C., Chatelain, P., & Clayton, P. (2021). Gene expression signatures predict response to therapy with growth hormone. The pharmacogenomics journal, 21(5), 594-607. https://doi.org/10.1038/s41397-021-00237-5
Stevens, Adam, et al. "Gene expression signatures predict response to therapy with growth hormone." The pharmacogenomics journal vol. 21,5 (2021): 594-607. doi: https://doi.org/10.1038/s41397-021-00237-5
Stevens A, Murray P, De Leonibus C, Garner T, Koledova E, Ambler G, Kapelari K, Binder G, Maghnie M, Zucchini S, Bashnina E, Skorodok J, Yeste D, Belgorosky A, Siguero JL, Coutant R, Vangsøy-Hansen E, Hagenäs L, Dahlgren J, Deal C, Chatelain P, Clayton P. Gene expression signatures predict response to therapy with growth hormone. Pharmacogenomics J. 2021 Oct;21(5):594-607. doi: 10.1038/s41397-021-00237-5. Epub 2021 May 27. PMID: 34045667; PMCID: PMC8455334.
Copy Download .nbib Format: NLM
Expression of bladder cancer-associated glycans in murine tumor cell lines.

Oncology letters

Albertó M, Cuello HA, Gulino CA, Pifano M, Belgorosky D, Gabri MR, Eiján AM, Segatori VI.
PMID: 30867744
Oncol Lett. 2019 Mar;17(3):3141-3150. doi: 10.3892/ol.2019.9995. Epub 2019 Jan 31.

The characterization of murine cell lines is of great importance in order to identify preclinical models that could resemble human diseases. Aberrant glycosylation includes the loss, excessive or novel expression of glycans and the appearance of truncated structures. MB49...

Cite
Albertó M, Cuello HA, Gulino CA, et al. Expression of bladder cancer-associated glycans in murine tumor cell lines. Oncol Lett. 2019;17(3):3141-3150doi: 10.3892/ol.2019.9995.
Albertó, M., Cuello, H. A., Gulino, C. A., Pifano, M., Belgorosky, D., Gabri, M. R., Eiján, A. M., & Segatori, V. I. (2019). Expression of bladder cancer-associated glycans in murine tumor cell lines. Oncology letters, 17(3), 3141-3150. https://doi.org/10.3892/ol.2019.9995
Albertó, Marina, et al. "Expression of bladder cancer-associated glycans in murine tumor cell lines." Oncology letters vol. 17,3 (2019): 3141-3150. doi: https://doi.org/10.3892/ol.2019.9995
Albertó M, Cuello HA, Gulino CA, Pifano M, Belgorosky D, Gabri MR, Eiján AM, Segatori VI. Expression of bladder cancer-associated glycans in murine tumor cell lines. Oncol Lett. 2019 Mar;17(3):3141-3150. doi: 10.3892/ol.2019.9995. Epub 2019 Jan 31. PMID: 30867744; PMCID: PMC6396118.
Copy Download .nbib Format: NLM
Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.

Frontiers in oncology

Mencucci MV, Lapyckyj L, Rosso M, Besso MJ, Belgorosky D, Isola M, Vanzulli S, Lodillinsky C, Eiján AM, Tejerizo JC, Gonzalez MI, Zubieta ME, Vazquez-Levin MH.
PMID: 32292715
Front Oncol. 2020 Mar 27;10:283. doi: 10.3389/fonc.2020.00283. eCollection 2020.

Bladder cancer (BC) is the ninth most common cancer worldwide, but molecular changes are still under study. During tumor progression, Epithelial cadherin (E-cadherin) expression is altered and β-catenin may be translocated to the nucleus, where it acts as co-transcription...

Cite
Mencucci MV, Lapyckyj L, Rosso M, et al. Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples. Front Oncol. 2020;10:283doi: 10.3389/fonc.2020.00283.
Mencucci, M. V., Lapyckyj, L., Rosso, M., Besso, M. J., Belgorosky, D., Isola, M., Vanzulli, S., Lodillinsky, C., Eiján, A. M., Tejerizo, J. C., Gonzalez, M. I., Zubieta, M. E., & Vazquez-Levin, M. H. (2020). Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples. Frontiers in oncology, 10283. https://doi.org/10.3389/fonc.2020.00283
Mencucci, María Victoria, et al. "Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples." Frontiers in oncology vol. 10 (2020): 283. doi: https://doi.org/10.3389/fonc.2020.00283
Mencucci MV, Lapyckyj L, Rosso M, Besso MJ, Belgorosky D, Isola M, Vanzulli S, Lodillinsky C, Eiján AM, Tejerizo JC, Gonzalez MI, Zubieta ME, Vazquez-Levin MH. Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples. Front Oncol. 2020 Mar 27;10:283. doi: 10.3389/fonc.2020.00283. eCollection 2020. PMID: 32292715; PMCID: PMC7119101.
Copy Download .nbib Format: NLM
Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center.

Journal of pediatric endocrinology & metabolism : JPEM

Mattone MC, Gil S, Costanzo M, Galluzzo Mutti ML, Casanovas A, Zaidman V, Lazzati JM, Ciaccio M, Belgorosky A, Guercio G.
PMID: 34674406
J Pediatr Endocrinol Metab. 2021 Oct 22;35(1):19-27. doi: 10.1515/jpem-2021-0392. Print 2022 Jan 27.

Pediatric adrenocortical tumors are rare and heterogeneous endocrine malignancies.OBJECTIVES: To report clinical, biochemical, and histological features, staging, and therapeutic interventions in a cohort of 28 patients treated at a single tertiary center.METHODS: A retrospective review of medical records of...

Cite
Mattone MC, Gil S, Costanzo M, et al. Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. J Pediatr Endocrinol Metab. 2021;35(1):19-27doi: 10.1515/jpem-2021-0392.
Mattone, M. C., Gil, S., Costanzo, M., Galluzzo Mutti, M. L., Casanovas, A., Zaidman, V., Lazzati, J. M., Ciaccio, M., Belgorosky, A., & Guercio, G. (2022). Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. Journal of pediatric endocrinology & metabolism : JPEM, 35(1), 19-27. https://doi.org/10.1515/jpem-2021-0392
Mattone, María Celeste, et al. "Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center." Journal of pediatric endocrinology & metabolism : JPEM vol. 35,1 (2022): 19-27. doi: https://doi.org/10.1515/jpem-2021-0392
Mattone MC, Gil S, Costanzo M, Galluzzo Mutti ML, Casanovas A, Zaidman V, Lazzati JM, Ciaccio M, Belgorosky A, Guercio G. Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center. J Pediatr Endocrinol Metab. 2021 Oct 22;35(1):19-27. doi: 10.1515/jpem-2021-0392. Print 2022 Jan 27. PMID: 34674406.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries